1. Home
  2. RLAY vs MYE Comparison

RLAY vs MYE Comparison

Compare RLAY & MYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • MYE
  • Stock Information
  • Founded
  • RLAY 2015
  • MYE 1933
  • Country
  • RLAY United States
  • MYE United States
  • Employees
  • RLAY N/A
  • MYE N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • MYE Auto Parts:O.E.M.
  • Sector
  • RLAY Health Care
  • MYE Consumer Discretionary
  • Exchange
  • RLAY Nasdaq
  • MYE Nasdaq
  • Market Cap
  • RLAY 619.0M
  • MYE 598.2M
  • IPO Year
  • RLAY 2020
  • MYE N/A
  • Fundamental
  • Price
  • RLAY $4.12
  • MYE $16.30
  • Analyst Decision
  • RLAY Strong Buy
  • MYE Buy
  • Analyst Count
  • RLAY 13
  • MYE 1
  • Target Price
  • RLAY $18.00
  • MYE $21.00
  • AVG Volume (30 Days)
  • RLAY 1.5M
  • MYE 215.7K
  • Earning Date
  • RLAY 11-05-2025
  • MYE 11-03-2025
  • Dividend Yield
  • RLAY N/A
  • MYE 3.31%
  • EPS Growth
  • RLAY N/A
  • MYE N/A
  • EPS
  • RLAY N/A
  • MYE 0.26
  • Revenue
  • RLAY $8,355,000.00
  • MYE $825,276,000.00
  • Revenue This Year
  • RLAY $31.55
  • MYE N/A
  • Revenue Next Year
  • RLAY N/A
  • MYE $1.94
  • P/E Ratio
  • RLAY N/A
  • MYE $62.49
  • Revenue Growth
  • RLAY N/A
  • MYE 1.11
  • 52 Week Low
  • RLAY $1.78
  • MYE $9.06
  • 52 Week High
  • RLAY $10.72
  • MYE $17.12
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 65.83
  • MYE 52.42
  • Support Level
  • RLAY $3.52
  • MYE $16.30
  • Resistance Level
  • RLAY $4.26
  • MYE $17.11
  • Average True Range (ATR)
  • RLAY 0.22
  • MYE 0.39
  • MACD
  • RLAY 0.07
  • MYE -0.06
  • Stochastic Oscillator
  • RLAY 85.26
  • MYE 31.09

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About MYE Myers Industries Inc.

Myers Industries Inc designs, manufactures, and markets a variety of plastic, metal, and rubber products, including a broad selection of plastic reusable containers, pallets, small parts bins, bulk shipping containers, storage and organization products, OEM parts, custom plastic products, consumer fuel containers and tanks for water, fuel and waste handling. It operates through the following segments: The Material Handling segment manufactures a selection of durable plastic reusable products that are used repeatedly during the course of their service life. The Distribution segment is engaged in the distribution of equipment, tools, and supplies used for tire servicing and automotive under-vehicle repair, etc. It generates the majority of its revenue from the Material Handling segment.

Share on Social Networks: